Sinobiomed Inc.
OTC Bulletin Board : SOBM

Sinobiomed Inc.

October 18, 2007 09:02 ET

Canadian Senator Larry W. Campbell Joins Sinobiomed Inc. as a Director

SHANGHAI, CHINA--(Marketwire - Oct. 18, 2007) - Sinobiomed Inc. ("Sinobiomed", or the "Company") (OTCBB:SOBM) is pleased to announce that Canadian Senator Larry W. Campbell has joined Sinobiomed's Board of Directors.

Senator Larry W. Campbell is 59 years old. Mr. Campbell joined the Royal Canadian Mounted Police in 1969, later joining the RCMP drug squad in 1973. In 1981, Mr. Campbell joined the British Columbia Coroner's Service in Vancouver and became the Chief Coroner for British Columbia in 1996. In 2002, he was elected as the Mayor of Vancouver, British Columbia. In August 2005, Mr. Campbell was summoned to the Senate of Canada by the Right Honourable Paul Martin. Senator Campbell is currently a member of the Senate Standing Committees on Aboriginal Peoples, Banking, Trade and Commerce, and Fisheries and Oceans. In addition, he is on the Board of Directors of the Canucks for Kids Foundation, CY Oriental Holdings Ltd., a listed public company on the TSX Venture Board, and sits on the Board of the Kaiser Foundation. Senator Campbell holds a Masters Degree in Business Administration (MBA) from City University in Vancouver, British Columbia.

"Sinobiomed is highly honoured to have Senator Campbell join our Board of Directors," said Company president and CEO Banjun Yang. "We believe that his unique combination of experience in both government and business will be an invaluable benefit to the Company."


Sinobiomed Inc. is a leading Chinese developer of genetically engineered recombinant protein drugs and vaccines. Based in Shanghai, Sinobiomed currently has 10 products approved or in development: three on the market, four in clinical trials and three in research and development. The Company's products respond to a wide range of diseases and conditions, including malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration.

FORWARD LOOKING STATEMENTS This news release may include "forward-looking statements" regarding Sinobiomed Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiomed Inc. expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Sinobiomed Inc. does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Contact Information